SCHEMBL24012229

SCHEMBL24012229

CC(C)(C)OC(=O)N1C[C@@](O)(c2ccccc2)C[C@@H]1C(=O)Nc1cc(C(N)(CCC2CC2)c2ccccn2)ccc1F

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 19/20 0.64
▸ F10 P00742 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24569877 0.91 KLKB1 (0.54) KLKB1F10
SCHEMBL24012283 0.91 KLKB1 (0.77) KLKB1
SCHEMBL24012270 0.90 KLKB1 (0.59) KLKB1F10
SCHEMBL20446625 0.87 KLKB1 (0.51) KLKB1F10
SCHEMBL31456826 0.87 KLKB1 (0.51) KLKB1F10
SCHEMBL20584591 0.87 KLKB1 (0.51) KLKB1F10
SCHEMBL20584584 0.86 KLKB1 (0.70) KLKB1F10
SCHEMBL29581201 0.86 KLKB1 (0.70) KLKB1F10
SCHEMBL24570331 0.85 KLKB1 (0.64) KLKB1
SCHEMBL20584567 0.85 KLKB1 (0.82) KLKB1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019022-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2022-06-29 — — EP disclosed
EP-3355890-B1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARM INC (US) 2021-11-10 — — EP disclosed
Send feedback